Processing Magazine

EU Approves Teva Acquisition of Ratiopharm

August 4, 2010
Bloomberg reports, Generic drugmaker Teva Pharmaceutical Industries Ltd. said it received European Commission approval to proceed with its acquisition of German drugmaker Ratiopharm and expects to close the transaction soon. The Israeli company said in March it agreed to buy the company for $5 billion in a deal intended to boost sales in Europe.